UOC
COCH icon

UBS O'Connor’s Envoy Medical COCH Stock Holding History

UBS O'Connor’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-427,660
Closed -$4.2M – 71
2022
Q3 		$4.2M Sell
427,660
-42,813
-9% -$420K 0.05% 344
2022
Q2 		$4.61M Buy
+470,473
New +$4.61M 0.05% 345
2022
Q1 		– Sell
-462,182
Closed -$4.51M – 43
2021
Q4 		$4.51M Buy
462,182
+12,378
+3% +$121K 0.04% 310
2021
Q3 		$4.36M Hold
449,804
– – 0.03% 337
2021
Q2 		$4.36M Buy
+449,804
New +$4.37M 0.04% 302

Other funds holding COCH

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

UBS O'Connor's COCH Position: Q4 2022 in Review

UBS O'Connor sold out of Envoy Medical (COCH) in Q4 2022, closing a stake of 427,660 shares — an estimated $4.2M sold.

UBS O'Connor first reported a position in COCH in Q2 2021 and held it in 5 quarters. The position peaked at $4.61M in Q2 2022. 93 funds tracked by Wall St. Rank hold COCH as of Q4 2022.

  • UBS O'Connor reported no remaining Envoy Medical position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 427,660 Envoy Medical shares in Q4 2022, an estimated $4.2M.
  • UBS O'Connor first reported a position in Envoy Medical in Q2 2021 and held it in 5 quarters.
  • UBS O'Connor's Envoy Medical position peaked at $4.61M in Q2 2022.
  • 93 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.